Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Rituximab and Lenalidomide (R 2 ) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Blood (2023) 142 (Supplement 1): 982.

https://doi.org/10.1182/blood-2023-174901

Published: 2023

Journal Articles

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL)

Blood (2021) 138 (Supplement 1): 811.

https://doi.org/10.1182/blood-2021-148581

Published: 2021

Journal Articles

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Stefania Bettelli, Raffaella Marcheselli, Samantha Manfredini, Alessia Bari, MD, Samantha Pozzi, MD, M. Christina Christina Cox, MD PhD, Luigi Marcheselli, Arianna Di Napoli, Ilana Levy, MD, Elisa Forti, Tamar Tadmor, MD, Antonino Maiorana, Stefano Sacchi, MD

Blood (2018) 132 (Supplement 1): 5308.

https://doi.org/10.1182/blood-2018-99-117973

Published: 2018

Journal Articles

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

Raffaella Marcheselli, PhD, Antonella Franceschetto, MD, Alessia Bari, MD, Luigi Marcheselli, MS, Tamar Tadmor, MD, Samantha Pozzi, MD, Ilana Levy, MD, Patrizia Pizzichini, MD, Daniela Prosperi, MD, Maria Christina Cox, MD, Rosaria D'Apollo, MD, Lucia Massi, MD, Napoleone Prandini, MD, Stefano Sacchi, MD

Blood (2017) 130 (Supplement 1): 1576.

https://doi.org/10.1182/blood.V130.Suppl_1.1576.1576

Published: 2017

Journal Articles

The Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of the End of Treatment 18-FDG-PET in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Raffaella Marcheselli, Antonella Franceschetto, Luigi Marcheselli, Alessia Bari, Samantha Pozzi, Monica Barbolini, Virginia Rossetti, Rosaria D'Apollo, Napoleone Prandini, Stefano Sacchi

Blood (2016) 128 (22): 5406.

https://doi.org/10.1182/blood.V128.22.5406.5406

Published: 2016

Journal Articles

Khorana Score and Histotype Predict the Incidence of Early Venous Thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). a Pooled Data Analysis of Twelve Clinical Trials of Fondazione Italiana Linfomi (FIL)

Blood (2015) 126 (23): 3934.

https://doi.org/10.1182/blood.V126.23.3934.3934

Published: 2015

Journal Articles

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Alessia Bari, Luigi Marcheselli, Tamar Tadmor, Raffaella Marcheselli, Maria Christina Cox, MDPhD, Samantha Pozzi, Angela Ferrari, Luca Baldini, Paolo Gobbi, Massimo Federico, Aaron Polliack, Stefano Sacchi

Blood (2015) 126 (23): 3862.

https://doi.org/10.1182/blood.V126.23.3862.3862

Published: 2015

Journal Articles

Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery

Monica Civallero, Viviana Vergaro, Cinzia Citti, Maria Cosenza, Giuseppe Cannazza, Carlo Parenti, Alessia Bari, Giuseppe Ciccarella, Stefano Sacchi, Samantha Pozzi

Blood (2015) 126 (23): 4851.

https://doi.org/10.1182/blood.V126.23.4851.4851

Published: 2015

Journal Articles

Neutrophil to Lymphocyte Ratio at Diagnosis Is an Independent Prognostic Factor in Diffuse Large B-Cell Lymphoma: Results of a Large Multicenter Study Involving 931 Patients

Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Tamar Tadmor, Samantha Pozzi, Maria Christina Cox, MDPhD, Luca Baldini, Angela Ferrari, Paola Ferri, Massimo Federico, Aaron Polliack, Stefano Sacchi

Blood (2015) 126 (23): 1465.

https://doi.org/10.1182/blood.V126.23.1465.1465

Published: 2015

Journal Articles

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD

Blood (2014) 124 (21): 499.

https://doi.org/10.1182/blood.V124.21.499.499

Published: 2014

Journal Articles

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, M. Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 3027.

https://doi.org/10.1182/blood.V124.21.3027.3027

Published: 2014

Journal Articles

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Luigi Marcheselli, Alessia Bari, MD, Samantha Pozzi, MD, Raffaella Marcheselli, Maria Christina Cox, MD, Luca Baldini, Prof, Stefano Luminari, MD, Stefano Sacchi, MD

Blood (2014) 124 (21): 5411.

https://doi.org/10.1182/blood.V124.21.5411.5411

Published: 2014

Journal Articles

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

Blood (2013) 122 (23): 3759–3766.

https://doi.org/10.1182/blood-2013-06-507319

Published: 2013

Includes: Supplemental data

Journal Articles

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Stefano Sacchi, MD, Samantha Pozzi, MD, Marina Cesaretti, Luigi Marcheselli, MS, Gabriele Buda, MD, Antonio Lazzaro, MD, Luca Baldini, Francesco Di Raimondo, MD, Pellegrino Musto, MD, Alfonso Zaccaria, Giorgina Specchia, Umberto Vitolo, MD, Massimo Magagnoli, MD, Franco Silvestris, MD, Pier Paolo Fattori, MD, Patrizia Tosi, MD, Eliana Valentina Liardo, MD, Alessia Bari, MD, Angelo Michele Carella

Blood (2013) 122 (21): 4383.

https://doi.org/10.1182/blood.V122.21.4383.4383

Published: 2013

Journal Articles

Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients

Stefano Sacchi, MD, Alessia Bari, MD, Tamar Tadmor, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Eliana Valentina Liardo, MD, Angela Ferrari, MD, Caterina Stelitano, Paolo G Gobbi, Prof, Luca Baldini, Daniele Vallisa, MD, Emilio Iannitto, MD, Aaron Polliack, MD, Massimo Federico

Blood (2013) 122 (21): 1754.

https://doi.org/10.1182/blood.V122.21.1754.1754

Published: 2013

Journal Articles

Romidepsin and Lenalidomide Show a Synergistic Effect In T–Cell Lymphoma Cell Lines

Maria Cosenza, MS, Monica Civallero, MS, PhD, Stefania Fiorcari, MS, Samantha Pozzi, MD, Luigi Marcheselli, Eliana Valentina Liardo, MD, Alessia Bari, MD, Stefano Sacchi, MD

Blood (2013) 122 (21): 5148.

https://doi.org/10.1182/blood.V122.21.5148.5148

Published: 2013

Journal Articles

Monocytosis Has Adverse Prognostic Significance and Impacts Survival in Patients with T-Cell Lymphomas.

Stefano Sacchi, Alessia Bari, MD, Tamar Tadmor, MD, Luigi Marcheselli, MS, Eliana Valentina Liardo, Samantha Pozzi, Stefano Luminari, MD, Luca Baldini, MD, Massimo Federico, MD, Aaron Polliack, MD

Blood (2012) 120 (21): 2647.

https://doi.org/10.1182/blood.V120.21.2647.2647

Published: 2012

Journal Articles

In Vitro Combination of Bortezomib with Enzastaurin or Lenalidomide Enhances the Cytotoxicity in B-Cell Lymphoma Cell Lines.

Maria Cosenza, MS, Monica Civallero, MS, PhD, Samantha Pozzi, Alessia Bari, MD, Eliana Valentina Liardo, Stefano Sacchi

Blood (2012) 120 (21): 2754.

https://doi.org/10.1182/blood.V120.21.2754.2754

Published: 2012

Journal Articles

Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)

Blood (2011) 118 (21): 777.

https://doi.org/10.1182/blood.V118.21.777.777

Published: 2011

Journal Articles

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Raffaella Marcheselli, MS, Alessia Bari, MD, Eliana Valentina Liardo, MD, Luigi Marcheselli, MS, Samantha Pozzi, MD, Stefano Sacchi, MD

Blood (2011) 118 (21): 5192.

https://doi.org/10.1182/blood.V118.21.5192.5192

Published: 2011

NARROW

Rituximab and Lenalidomide (R 2 ) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL)

Prognostication of Diffuse Large B-Cell Lymphoma By Lympho2Cx Assay and BCL2 and MYC Expression: Application in a Real Life Context of 154 Patients

Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of Final FDG-PET in Diffuse Large B Cell Lymphoma Patients

The Absolute Monocyte Count at Diagnosis Could Improve the Prognostic Role of the End of Treatment 18-FDG-PET in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Khorana Score and Histotype Predict the Incidence of Early Venous Thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). a Pooled Data Analysis of Twelve Clinical Trials of Fondazione Italiana Linfomi (FIL)

Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients

Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery

Neutrophil to Lymphocyte Ratio at Diagnosis Is an Independent Prognostic Factor in Diffuse Large B-Cell Lymphoma: Results of a Large Multicenter Study Involving 931 Patients

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Are Absolute Monocyte Count and The Lymphocyte-Monocyte Ratio (LMR) Valid Prognostic Factors In Classical Hodgkin Lymphoma? An Evaluation Based On Data From 1079 Patients

Romidepsin and Lenalidomide Show a Synergistic Effect In T–Cell Lymphoma Cell Lines

Monocytosis Has Adverse Prognostic Significance and Impacts Survival in Patients with T-Cell Lymphomas.

In Vitro Combination of Bortezomib with Enzastaurin or Lenalidomide Enhances the Cytotoxicity in B-Cell Lymphoma Cell Lines.

Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)

Secondary Leukemia After Non-Hodgkin Lymphoma: A Systematic Review and a Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only